A Revision Arthrodesis of Severe Charcot Foot with Intramedullary Nail: a Case Report and Literature Review
PDF

Keywords

Charcot foot
arthrodesis
nail

Abstract

Diabetic Charcot foot is characterized by varying degrees of bone and joint disorganization secondary to underlying neuropathy, perturbations of bone metabolism and trauma. Offloading is the most important initial treatment recommendation. Surgery can be helpful in early stages involving acute fractures of the foot or ankle or in later stages when offloading is ineffective. Incorrect diagnosis and improper treatment often result in the extremity having to be amputated.     There are several surgical procedures accepted in Charcot foot surgery. Their goal is to obtain a plantigrade foot and prevent recurrent ulcerations. Arthrodesis is a well-known surgical procedure that addresses severe joint derangement through a surgically induced bony fusion. In Charcot foot, arthrodesis is usually indicated when there is significant skeletal instability. This procedure can be done by internal or external fixation.
https://doi.org/10.21802/gmj.2019.1.8
PDF

References

Ashford RL, Mc Gee P, Kinmond K. Perception of quality of life by patients with diabetic foot ulcers. The Diabetic Foot. 2000; 3: 150-155.

Boyko EJ, Ahroni JH, Smith DG, Davignon D. Increased mortality associated with diabetic foot ulcer. Diabet Med. 1996; 13: 967-972. DOI: https://doi.org/10.1002/(SICI)1096-9136(199611)13:11<967::AID-DIA266>3.0.CO;2-K

Patou CA, Birke JA, Horswell R, Williams D, Cerise FP. Effectiveness of a comprehensive diabetes lower – extremity ampuation prevention program in a predominantly low income African-American population. Diabetes Care. 2000; 23: 1339-1342. DOI: https://doi.org/10.2337/diacare.23.9.1339

Molines L, Darmon P, Raccah D. Charcot's foot: Newest findings on its pathophysiology, diagnosis and treatment. Diabetes Metab. 2010; 36: 251-255. DOI: https://doi.org/10.1016/j.diabet.2010.04.002 [PMid:20570543]

Boulton A, Amstrong D, Albert S, et al. Comprehensive foot examination and risk assessment: A report of the task force of the foot care interest group of the American Diabetes Association. Diabetes Care. 2008; 31: 1679-1685. DOI: https://doi.org/10.2337/dc08-9021 [PMid:18663232 PMCid:PMC2494620]

Sanders LJ, Frykberg RG. Diabetic neuropathic osteoarthropathy: the Charcot foot. The High Risk Foot in Diabetes Mellitus. 1993; 297-336.

Frykberg RG, Belczyk R. Epidemiology ot the Charcot foot. Clin Podiatr Med Surg. 2008; 25: 17-28. DOI: https://doi.org/10.1016/j.cpm.2007.10.001 [PMid:18165108]

Armstrong DG, Lavery LA. Elevated peak plantar pressures in patients who have Charcot arthropathy. J Bone Joint Surg. 1998; 80(3): 365-369. DOI: https://doi.org/10.2106/00004623-199803000-00009

Lacey DL, Boyle WJ, Simonet S, et al. Bench to bedside: Elucidation of the OPG-RANK-RANK-L pathway and the development of denosumab. Nat Rev Drug Discov. 2012; 11: 401-419. DOI: https://doi.org/10.1038/nrd3705 [PMid:22543469]

Jehan S, Shakeel M, Bing AJ, et al. The success of tibiotalocal-caneal arthrodesis with intramedullary nailing—a systematic review of the literature. Acta Orthop Belg. 2011; 77(5): 644-651. [PMid:22187841]

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Downloads

Download data is not yet available.